These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37830460)
1. CD44 targeted delivery of hyaluronic acid-coated polymeric nanoparticles against colorectal cancer. Phatak N; Bhattacharya S; Shah D; Manthalkar L; Sreelaya P; Jain A Nanomedicine (Lond); 2023 Oct; 18(23):1613-1634. PubMed ID: 37830460 [No Abstract] [Full Text] [Related]
2. Design and evaluation of hyaluronic acid-coated PLGA nanoparticles of raloxifene hydrochloride for treatment of breast cancer. Bhatt K; Patil P; Jani P; Thakkar P; Sawant K Drug Dev Ind Pharm; 2021 Dec; 47(12):2013-2024. PubMed ID: 35686735 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Wang S; Zhang J; Wang Y; Chen M Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968 [TBL] [Abstract][Full Text] [Related]
5. Self-assembled polymeric micelles based on hyaluronic acid-g-poly(D,L-lactide-co-glycolide) copolymer for tumor targeting. Son GM; Kim HY; Ryu JH; Chu CW; Kang DH; Park SB; Jeong YI Int J Mol Sci; 2014 Sep; 15(9):16057-68. PubMed ID: 25216338 [TBL] [Abstract][Full Text] [Related]
6. HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. Yang B; Mao Y; Zhang Y; Hao Y; Guo M; Li B; Peng H Molecules; 2023 Nov; 28(22):. PubMed ID: 38005286 [TBL] [Abstract][Full Text] [Related]
7. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells. Cerqueira BBS; Lasham A; Shelling AN; Al-Kassas R Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():593-600. PubMed ID: 28482569 [TBL] [Abstract][Full Text] [Related]
8. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells. Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759 [TBL] [Abstract][Full Text] [Related]
10. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329 [TBL] [Abstract][Full Text] [Related]
12. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
13. Targeting pentamidine towards CD44-overexpressing cells using hyaluronated lipid-polymer hybrid nanoparticles. Andreana I; Chiapasco M; Bincoletto V; Digiovanni S; Manzoli M; Ricci C; Del Favero E; Riganti C; Arpicco S; Stella B Drug Deliv Transl Res; 2024 Aug; 14(8):2100-2111. PubMed ID: 38709442 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer. Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268 [TBL] [Abstract][Full Text] [Related]
15. Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy. Pan C; Zhang T; Li S; Xu Z; Pan B; Xu S; Jin S; Lu G; Yang S; Xue Z; Chen P; Shen X; Wang F; Xu C Int J Nanomedicine; 2021; 16():1743-1755. PubMed ID: 33688189 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948 [TBL] [Abstract][Full Text] [Related]
17. Self-assembled nanoparticles of hyaluronic acid/poly(DL-lactide-co-glycolide) block copolymer. Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH Colloids Surf B Biointerfaces; 2012 Feb; 90():28-35. PubMed ID: 22001557 [TBL] [Abstract][Full Text] [Related]
18. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer. Bhattacharya S Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222 [TBL] [Abstract][Full Text] [Related]
19. Targeted polymeric nanoparticle for anthracycline delivery in hypoxia-induced drug resistance in metastatic breast cancer cells. Almoustafa HA; Alshawsh MA; Chik Z Anticancer Drugs; 2021 Aug; 32(7):745-754. PubMed ID: 33675612 [TBL] [Abstract][Full Text] [Related]
20. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure. Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]